TIEFENBACHER GROUP becomes member of the Pharmaceutical Supply Chain Initiative (PSCI)

We at TIEFENBACHER GROUP are committed to promote sustainable and responsible business along the whole pharmaceutical supply chain. That’s why we are excited to become a member of PSCI – a non-profit business membership organization striving for better social, health, safety, and environmental outcomes in pharmaceutical supply chains. It follows our company´s strategy to make medicines better affordable, better available, and better than before in a sustainable way – better for people and the planet!

PSCI is a group of international pharmaceutical and healthcare companies who share together the vision of responsible supply chains. The organization was founded in 2006 and is legally established in the United States. Today PSCI already counts 63 members. For more information about the organization have a look at: PSCI (pscinitiative.org) .

For further information about our product portfolio and innovative health care solutions for a better tomorrow please contact TIEFENBACHER GROUP: info@aet.eu or visit us on: www.tiefenbachergroup.com

About TIEFENBACHER GROUP – Pioneering Healthcare since 1963

TIEFENBACHER GROUP is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From initial idea to market access of high-quality pharmaceuticals around the world: We distribute APIs and develop, manufacture, and register finished dosage forms (FDF) as well as medical devices. Our purpose is to improve patients´ lives by creating pharmaceuticals more affordable, more available, and better than before.


TIEFENBACHER GROUP OPENS NEW SITE FOR HIGHLY POTENT DRUGS IN INDIA

TIEFENBACHER GROUP is excited to announce the ceremonious opening of our new highly potent drug laboratory in Hyderabad, India. The completion of the new building is the first step for TIEFENBACHER GROUP to become a leading global developer and manufacturer of highly potent drugs for the treatment of cancer and other diseases. It follows our company´s strategy to make medicines more affordable, more available, and better than before.

The lab is equipped with the latest techniques with full safety protection measurements and will be extended by an additional manufacturing block with special technologies in 2023. The new complex will cover a total of about 4.000 square meters.

TIEFENBACHER PHARMACEUTICALS (FDF business unit of TIEFENBACHER GROUP) has already 25 leading highly potent drugs in its launch pipeline which are planned to be developed and produced in the new facilities in Hyderabad. While the operational start of the lab (including small-scale production) is planned for this year, the commercial production for larger quantities in the new manufacturing block is expected for 2024.

For further information about our product portfolio and innovative health care solutions for a better tomorrow please contact TIEFENBACHER GROUP: info@aet.eu or visit us on: www.tiefenbachergroup.com

About TIEFENBACHER GROUP – Pioneering Healthcare since 1963

TIEFENBACHER GROUP is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From initial idea to market access of high-quality pharmaceuticals around the world: We distribute APIs and develop, manufacture, and register finished dosage forms (FDF) as well as medical devices. Our purpose is to improve patients´ lives by creating pharmaceuticals more affordable, more available, and better than before.


WORLD HEALTH DAY @ TIEFENBACHER GROUP

Today we celebrate World Health Day. In times of a global pandemic and a cruel war in Europe, it is more important than ever that we all work together to create a healthier tomorrow. Since 1963 we at TIEFENBACHER GROUP are pioneering healthcare to improve patients´ lives around the world. Today we serve over 500 million patients every year with our pharmaceutical products and innovative healthcare solutions. In everything we do we are led by three questions: are we making high-quality pharmaceuticals better affordable, better globally available, or better than before?

For information about our product portfolio and innovative healthcare solutions please contact TIEFENBACHER GROUP: info@aet.eu or visit us on: www.tiefenbachergroup.com

About TIEFENBACHER GROUP – Pioneering Healthcare since 1963

TIEFENBACHER GROUP is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. Our purpose is to improve
patients´ lives by creating pharmaceuticals more affordable, more available, and better than before.


Featured Video Play Icon

TIEFENBACHER GROUP AT DCAT 2022 – THANKS FOR MEETING US IN NEW YORK CITY!

One of the world´s most important pharma events – DCAT week in New York City – has just come to an end. It was four very successful and inspiring days for TIEFENBACHER GROUP presenting our latest product portfolio and innovations to our existing and potential new partners. Check out our short video to get some impressions!

For further information about our product portfolio and innovative health care solutions please contact TIEFENBACHER GROUP: info@aet.eu or visit us on: www.tiefenbachergroup.com

About TIEFENBACHER GROUP – Pioneering Healthcare since 1963
TIEFENBACHER GROUP is a purpose-driven and 100% family-owned healthcare company providing solutions along the entire pharmaceutical value chain. Our purpose is to improve patients´ lives by creating pharmaceuticals more affordable, more available, and better than before.


TIEFENBACHER GROUP STANDS WITH UKRAINE

To us at TIEFENBACHER GROUP, it is unbearable to witness what is happening in Ukraine. We condemn the Russian state´s invasion as a brutal act of war against a neighbouring sovereign country. Our thoughts are with everyone affected by this war. We stand with all Ukrainians and have already donated urgently needed medicine to a hospital in Kyiv and are currently checking further supply options. To support emergency aid for children and families in Ukraine we have also made a significant monetary donation to UNICEF.

About TIEFENBACHER GROUP – Pioneering Healthcare since 1963

TIEFENBACHER GROUP is a value-driven and patient-focused healthcare company providing solutions along the entire pharmaceutical value chain. Our purpose is to improve patients´ lives by creating pharmaceuticals more affordable, more available, and better than before.

For information about our product portfolio and innovative health care solutions please contact TIEFENBACHER GROUP: info@aet.eu or visit us on: www.tiefenbachergroup.com


MEET TIEFENBACHER GROUP DURING DCAT WEEK IN NEW YORK CITY FROM 21-24th MARCH!

Reach out to TIEFENBACHER GROUP at DCAT in New York City from 21-24th March and discover our latest ideas to make pharmaceuticals more affordable, more available, and better than before! Contact us to schedule a meeting via info@aet.eu.

For information about our product portfolio and innovative health care solutions please contact TIEFENBACHER GROUP: info@aet.eu or visit us on: www.tiefenbachergroup.com

About TIEFENBACHER GROUP – Pioneering Healthcare since 1963

TIEFENBACHER GROUP is a value-driven and patient-focused healthcare company providing solutions along the entire pharmaceutical value chain. Our purpose is to improve patients ́ lives by creating pharmaceuticals more affordable, more available, and better than before.


Featured Video Play Icon

TIEFENBACHER GROUP WISHES A HAPPY AND HEALTHY NEW YEAR 2022 FROM ALL OVER THE WORLD!

We at TIEFENBACHER GROUP wish you a happy and healthy new year 2022 from all over the world! Please watch the short video for our new year greetings from our colleagues from our three main locations in Hamburg (Germany), Hyderabad (India) and Lefkosia (Cyprus).

For information about our product portfolio and innovative health care solutions please contact TIEFENBACHER GROUP: info@aet.eu or visit us on: www.tiefenbachergroup.com

About TIEFENBACHER GROUP – Pioneering Healthcare since 1963

TIEFENBACHER GROUP is a value-driven and patient-focused healthcare company providing solutions along the entire pharmaceutical value chain. Our purpose is to improve patients ́ lives by creating pharmaceuticals more affordable, more available, and better than before.


Featured Video Play Icon

Three successful days for TIEFENBACHER GROUP at CPhI 2021 – thanks for visiting us in Milano!

With over 1,300 exhibitors and more than 20,000 attendees the world`s leading pharma event CPhI has just come to an end. It was three very successful days for TIEFENBACHER GROUP presenting our latest product portfolio and innovations at Fiera Milano. After two years of mainly digital work it was a great experience to finally meet our valued customers and partners in person again. Our experts have come home with lots of new inspirations and business ideas and are already looking forward to reconnecting soon. Check out our short video to get an impression of our brand-new booth representing TIEFENBACHER GROUP as a global health pioneer.

FFor further information about our product portfolio and innovative health care solutions please contact TIEFENBACHER GROUP: info@aet.eu or visit us on: www.tiefenbachergroup.com

About TIEFENBACHER GROUP – Pioneering Healthcare since 1963

TIEFENBACHER GROUP is a value-driven and patient-focused healthcare company providing solutions along the entire pharmaceutical value chain. Our purpose is to improve patients´ lives by creating pharmaceuticals more affordable, more available and better than before.


Featured Video Play Icon

At TIEFENBACHER GROUP giving back to society is important to us: New school building in India

As a value-driven healthcare company, dedicated to improve the life of patients worldwide, we believe that it´s our responsibility to care about the environment and society – especially in the countries in which we operate.

That’s why we are happy to share that we have build up a new school next to our own R&D and manufacturing facilities in Hyderabad, India, to improve the education and health of the children in our neighborhood. The “Anganwadi school” follows international standards of Kindergarten and has already started to educate 25 children from Alinagar village in the age of 3-8. With this initiative we give underprivileged children from poor families the chance to have a better future through better education and nutrition.

Anganwadi is a type of rural child care center in India. They were started by the Indian government in 1975 as part of the Integrated Child Development Services program to improve the nutrition and health status of children and to reduce morbidity, mortality and school dropout – laying the foundation for holistic development of children.

For TIEFENBACHER GROUP it is a rewarding experience to give back to the community. Our caring culture is fundamental to achieve our purpose to make everyday life significantly better for people around the world. We will continue promoting education and health in various community engagement projects that are in line with our values and beliefs.

For further information about our corporate responsibility or our worldwide health care solutions please contact TIEFENBACHER GROUP: info@aet.eu or visit us on: www.tiefenbachergroup.com

About TIEFENBACHER GROUP – Pioneering Healthcare since 1963

TIEFENBACHER GROUP is a value-driven and patient-focused healthcare company providing solutions along the entire pharmaceutical value chain. Our purpose is to improve patients´ lives by creating pharmaceuticals more affordable, more available and better than before.


Reach out to TIEFENBACHER GROUP at CPhI in Milan from 9-11th Nov and discover our latest ideas to make pharmaceuticals more affordable, more available and better than before!

“Nothing can replace meeting each other in person!” says Oliver Schrader, Managing Director of Tiefenbacher Group. After nearly two years of mainly digital work, we are very excited to be back on the world´s leading pharma industry event CPhI in Milan to meet our valued customers and partners finally in person again.

Explore our brand-new booth representing Tiefenbacher Group as a global health pioneer and discover our latest product portfolio and innovations! Connect with our experts to discuss new business opportunities and ideas for improving the life of millions of patients worldwide!

CPhI 2021 will take place on November 9-11th at Fiera Milano, Italy. We’ll be happy to meet you at our stand 3H11. The arrangement of prescheduled meetings is highly appreciated due to Covid-19 and limited booth time and space. Please contact our team to request a meeting or send a meeting request to cphi@aet.eu.

TIEFENBACHER GROUP – pioneering healthcare since 1963. Please visit us on www.tiefenbachergroup.com